Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Duarte California

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Los Angeles California 90027

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Los Angeles California

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Sacramento California

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

San Diego California 92122

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

View More ▼

San Francisco California 94143

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

District of Columbia

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Florida

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating Ankle and Knee Ultrasound Joint Assessment and Ankle and Knee Magnetic Resonance Imaging for the treatment of Hemophilia A or Hemophilia B

St. Petersburg Florida 33701

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Tampa Florida 33607

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Georgia

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Illinois

Chicago Illinois

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Peoria Illinois

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Peoria Illinois 61615

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Indiana

Indianapolis Indiana 46260

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Indianapolis Indiana

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Maine

Scarborough Maine 04074

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Maryland

Baltimore Maryland 21205

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

St. Louis Maryland 63104

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Massachusetts

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Michigan

East Lansing Michigan 48823

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

East Lansing Michigan 48823

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Minnesota

Minneapolis Minnesota 55404

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Nevada

Las Vegas Nevada 89109

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

New Hampshire

Lebanon New Hampshire 03756

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

New York

Rochester New York 14621

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Ohio

Columbus Ohio 43205

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Oregon

Portland Oregon 97239

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Pennsylvania

Hershey Pennsylvania

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Pittsburgh Pennsylvania

A clinical trial to evaluate treatments using ALN-AT3SC for patients with Moderate or Severe Hemophilia A or Hemophilia B

Pittsburgh Pennsylvania

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

View More ▼

Pittsburgh Pennsylvania 15213

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Texas

Dallas Texas

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Dallas Texas 75235

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Houston Texas

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Washington

Seattle Washington 98104

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Wisconsin

Milwaukee Wisconsin 53201

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Australia

Brisbane 4029

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Parkville 3052

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Perth 6008

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Westmead 2145

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Bulgaria

Plovdiv

A clinical trial to evaluate treatments using ALN-AT3SC for patients with Moderate or Severe Hemophilia A or Hemophilia B

Sofia

A clinical trial to evaluate treatments using ALN-AT3SC for patients with Moderate or Severe Hemophilia A or Hemophilia B

Varna

A clinical trial to evaluate treatments using ALN-AT3SC for patients with Moderate or Severe Hemophilia A or Hemophilia B

Canada

Hamilton L8N 3Z5

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

London N6A 4G5

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Toronto M5G 1X8

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Toronto Ontario M5G 1X8

A clinical trial seeking patients for a research study for the treatment of Hemophilia or Hemophilic Arthropathy